Few drugs likely to qualify for Trump administration's importation plan

Two new pathways the Trump administration proposed Wednesday would allow for the first time importation of drugs for sale in the U.S., but the highest-priced, most profitable drugs on the market would be unlikely to be affected by the changes.

One pathway would allow importation from Canada via certain intermediaries for a limited number of

Read the full 546 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE